Plant Name: Solanum virginianum
Taxonomic Information:
Plant ID: NPO11662
Plant Latin Name: Solanum virginianum
Taxonomy Genus: Solanum
Taxonomy Family: Solanaceae
Plant External Links:
NCBI TaxonomyDB:
223891
Plant-of-the-World-Online:
821496-1
Used in Medicines:
Country/Region:
IndiaTraditional Medicine System:
Geographical Distribution:
Afghanistan; India; China; Thailand; Sri Lanka; Japan; Taiwan
Geographical Distribution
See the Plant Occurrence Worldwide with Latitude and Longitude Available
Collective Molecular Activities of the Plant
List of Human Proteins Collectively Targeted by the Plant
Click Gene ID to Access Activity Profile of Individual Target
| ALOX15; | |
| CASP7; CASP1; | |
| HIF1A; | |
| SLCO1B3; | |
| XDH; |
List of Human Cytochrome P450 Enzymes Affected by the Plant
Click Gene ID to Access Activity Profile of Individual Enzyme
| Cytochrome P450 Enzymes: |
|---|
Detailed Information of Target Proteins
| Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
|---|---|---|---|---|
| Cysteine protease | CASP7 | Caspase-7 | P55210 | CHEMBL3468 |
| Cysteine protease | CASP1 | Caspase-1 | P29466 | CHEMBL4801 |
| Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
| Oxidoreductase | XDH | Xanthine dehydrogenase | P47989 | CHEMBL1929 |
| SLC superfamily of solute carriers | SLCO1B3 | Solute carrier organic anion transporter family member 1B3 | Q9NPD5 | CHEMBL1743121 |
| Transcription Factor | HIF1A | Hypoxia-inducible factor 1 alpha | Q16665 | CHEMBL4261 |
Enrichment of Gene Ontology of Target Proteins (Activity≤10μM)
Detailed Information of Enriched Gene Ontolgy
| GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
|---|---|---|---|---|---|
| BP | GO:0065007; biological regulation | GO:0006919; activation of cysteine-type endopeptidase activity involved in apoptotic process | 1.461E-06 | 3.182E-02 | CASP1, CASP7, XDH |
| MF | GO:0003824; catalytic activity | GO:0097200; cysteine-type endopeptidase activity involved in execution phase of apoptosis | 6.262E-06 | 3.409E-02 | CASP1, CASP7 |
| BP | GO:0009987; cellular process | GO:0097194; execution phase of apoptosis | 5.625E-05 | 1.225E-01 | CASP1, CASP7 |
| BP | GO:0032502; developmental process | GO:0007595; lactation | 6.558E-05 | 1.298E-01 | HIF1A, XDH |
| BP | GO:0009987; cellular process | GO:0001961; positive regulation of cytokine-mediated signaling pathway | 7.220E-05 | 1.310E-01 | CASP1, HIF1A |
| MF | GO:0003824; catalytic activity | GO:0047977; hepoxilin-epoxide hydrolase activity | 6.212E-04 | 2.940E-01 | ALOX15 |
| MF | GO:0003824; catalytic activity | GO:0051120; hepoxilin A3 synthase activity | 9.316E-04 | 3.074E-01 | ALOX15 |
| CC | GO:0044464; cell part | GO:0005829; cytosol | 4.678E-03 | 6.063E-01 | ALOX15, CASP1, CASP7, HIF1A, XDH |
| CC | GO:0044425; membrane part | GO:0019897; extrinsic component of plasma membrane | 3.188E-02 | 1.000E+00 | ALOX15 |
Enriched KEGG Pathways of Target Proteins (Activity≤10μM)
Top 10 KEGG Pathways (ordered by adjusted p-value)
Detailed Information of Enriched KEGG Pathways
| Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
|---|---|---|---|---|---|---|
| 09160 Human Diseases | 09167 Infectious diseases | hsa05134 | Legionellosis | 1.106E-04 | 2.886E-03 | CASP7, CASP1 |
| 09160 Human Diseases | 09167 Infectious diseases | hsa05133 | Pertussis | 2.061E-04 | 2.886E-03 | CASP7, CASP1 |
| 09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 8.670E-03 | 4.548E-02 | ALOX15 |
| 09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00983 | Drug metabolism - other enzymes | 1.372E-02 | 4.548E-02 | XDH |
| 09130 Environmental Information Processing | 09132 Signal transduction | hsa04150 | mTOR signaling pathway | 1.787E-02 | 4.548E-02 | HIF1A |
| 09160 Human Diseases | 09163 Neurodegenerative diseases | hsa05014 | Amyotrophic lateral sclerosis (ALS) | 1.520E-02 | 4.548E-02 | CASP1 |
| 09100 Metabolism | 09110 Biosynthesis of other secondary metabolites | hsa00232 | Caffeine metabolism | 1.499E-03 | 1.399E-02 | XDH |
| 09160 Human Diseases | 09161 Cancers | hsa05230 | Central carbon metabolism in cancer | 1.993E-02 | 4.548E-02 | HIF1A |
| 09150 Organismal Systems | 09151 Immune system | hsa04623 | Cytosolic DNA-sensing pathway | 1.905E-02 | 4.548E-02 | CASP1 |
| 09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 2.111E-02 | 4.548E-02 | SLCO1B3 |
Human Diseases Associated with the Target Proteins of the Plant
Detailed Information of Human Diseases
| ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
|---|
>> Profiles of ingredients and activity landscape
>> Targets derived from weak experimental activities
